Ibotta’s stock price has taken a beating over the past six months, shedding 32.8% of its value and falling to $48.94 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
A number of stocks jumped in the afternoon session after investor sentiment improved on renewed optimism that the US-China trade conflict might be nearing a resolution. According to reports, Treasury Secretary Scott Bessent reinforced this positive outlook by describing the trade war as "unsustainable," and emphasized that a potential agreement between the two economic powers "was possible."
His comments signaled to markets that both sides might be motivated to seek common ground, raising expectations for reduced tariffs and more stability across markets.
A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth. Trump's comments added pressure to an already sensitive market, raising concerns about political interference in monetary policy.
Looking back on advertising & marketing services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Ibotta (NYSE:IBTA) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the advertising & marketing services industry, including Taboola (NASDAQ:TBLA) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how advertising & marketing services stocks fared in Q4, starting with Interpublic Group (NYSE:IPG).
U.S. bans Chinese AI model DeepSeek on government devices due to national security concerns. Google's parent Alphabet acquires Wiz for $32B. Foxconn CEO criticizes Trump's tariff policy. Baidu launches AI models to rival competitors. iRobot faces competition from Chinese rivals. LinkedIn co-founder warns against Elon Musk's influence on US government.
Short seller The Bear Cave has taken a swipe at Ibotta Inc (NYSE:IBTA) in a new report highlighting slowing growth and collapsing customer and employee relationships.
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.
